Huisheng Biotech (300871.SZ) released its report for the first quarter of 2024. The company's revenue was 2.07...
According to the Zhitong Finance App, Huisheng Biotech (300871.SZ) released its report for the first quarter of 2024. The company's revenue was 207 million yuan, a decrease of 10.24% over the previous year. The net loss attributable to shareholders of the listed company was RMB 16.4056 million. The net loss attributable to shareholders of the listed company after deducting non-recurring profit and loss was $8.2836 million. The basic loss per share was $0.0989.